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ABSTRACT
The United States is in the midst of an opioid epidemic with recent estimates in-
dicating that more than 130 people die every day due to drug overdose. The over-
prescription and addiction to opioid painkillers, heroin, and synthetic opioids, has
led to a public health crisis and created a huge social and economic burden. Sta-
tistical learning methods that use data from multiple clinical centers across the US
to detect opioid over-prescribing trends and predict possible opioid misuse are re-
quired. However, the semantic heterogeneity in the representation of clinical data
across different centers makes the development and evaluation of such methods
difficult and non-trivial. We create the Opioid Drug Knowledge Graph (ODKG)
– a network of opioid-related drugs, active ingredients, formulations, combina-
tions, and brand names. We use the ODKG to normalize drug strings in a clinical
data warehouse consisting of patient data from over 400 healthcare facilities in 42
different states. We showcase the use of ODKG to generate summary statistics of
opioid prescription trends across US regions. These methods and resources can aid
the development of advanced and scalable models to monitor the opioid epidemic
and to detect illicit opioid misuse behavior. Our work is relevant to policymakers
and pain researchers who wish to systematically assess factors that contribute to
opioid over-prescribing and iatrogenic opioid addiction in the US.
1 THE OPIOID EPIDEMIC IN THE UNITED STATES
The opioid abuse epidemic is one of the most challenging public health challenges that our nation has
ever faced. The US FDA declared the over-prescribing of opioid painkillers to be a leading cause of
the astronomical rise in opioid addiction, with 64,000 overdose deaths in 2016 and 2 million people
currently addicted (McCance-Katzr et al., 2010). Under current conditions, the annual number of
opioid overdose deaths in US is projected to reach nearly 82,000 by 2025, resulting in approximately
700,000 deaths from 2016 to 2025 (Chen et al., 2019). With eight states reporting more opioid
prescriptions than residents (Reuben et al., 2015), modifying current prescribing practices is an
important strategy for reducing surging rates of opioid overdoses in the US.
To gain a better understanding on opioid prescription trends across the entire United States and to
predict possible opioid abuse behavior in patients, it is imperative to build statistical models using
clinical data from multiple healthcare sites in the US. However, due to the vast semantic hetero-
geneity that still exists between different clinical systems (Sujansky, 2001), and the lack of use of
standard terminologies to encode clinical features (e.g., patient medications), developing such sta-
tistical models is difficult. Raw patient data is often extracted from legacy databases across multiple
clinical centers and transformed under a uniform representation format (e.g., Fast Healthcare Inter-
operability Resources format (Shickel et al., 2018) and OMOP Common Data Model (Hripcsak
et al., 2015)) for use in these machine learning models. This is a burden on the side of the clinical
centers and leads to the creation of multiple copies of private and secure patient data.
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Table 1: First degree hops from the generic ingredient Morphine in the ODKG, listing few examples of different
drug formulations, combinations, and tradenames.
Property Type Example Classes
Part Of Atropine / Morphine, Cyclizine / Morphine, Morphine / Naltrexone
Has Tradename MS Contin, EMbeda, Avinza, Duramorph, Kadian
Has Form Morphine Hydrochloride, Morphine Sulphate, Morphine Tartrate
Ingredient Of Morphine Injectable Solution, Morphine Prefilled Syringe, Morphine / Naltrexone Ex-
tended Release Oral Tablet, Morphine Sulfate 20 MG/ML, Morphine hydrochloride 40 MG
Knowledge graphs can aid in the task of normalization of similar entities encoded using different
identifiers and enable integration of data from multiple heterogeneous sources. Knowledge graphs
are large directed networks of real-world entities and relations between those entities, with a fixed
set of semantic classes and properties (Ehrlinger & Wo¨ß, 2016). Knowledge graphs constructed
from multiple, heterogeneous pharmacological data sources have been used to predict adverse side
effects that manifest on the account of polypharmacy (Zitnik et al., 2018; Kamdar & Musen, 2017).
In this paper, we describe our efforts to create an Opioid Drug Knowledge Graph (ODKG). We
use the ODKG to normalize drug strings from a data warehouse consisting of electronic medical
record (EMR) data that was collected from one vendor with installations in 42 states in the US. We
showcase how the ODKG can aid in generating summary statistics on the prescription of different
opioids in the US. Finally, we will discuss potential applications of using the ODKG to develop a
web-based US compendium that allows for exploring and visualizing opioid prescribing across the
US. Although such tools exist to examine international opioid consumption trends (Sankaran et al.,
2016; Gebert et al., 2018), there is no such resource for the greater US.
2 METHODS
2.1 GENERATION OF THE OPIOID DRUG KNOWLEDGE GRAPH
We use two terminologies to generate the Opioid Drug Knowledge Graph (ODKG): T1) ATC
(WHO, 2003): Active ingredients of drugs classified according to their anatomical, therapeutic,
and chemical properties, and T2) RxNorm (Liu et al., 2005): Standard names for clinical drugs
and dosage forms, as well as relations between clinical drugs to their active ingredients, drug com-
ponents, and related brand names. Both these terminologies are members of the Unified Medical
Language System (UMLS) (Bodenreider, 2004) and are retrieved from the BioPortal repository of
biomedical ontologies and terminologies (Whetzel et al., 2011). UMLS uses the notion of a Concept
Unique Identifier (CUI) to map classes with similar meaning in different terminologies.
In the first step, we use hierarchical reasoning to retrieve all the descendants of five base opioid-
related classes in the ATC terminology: (N02A) Opioid analgesics, (N01AH) Opioid anesthetics,
(R05DA) Opium alkaloids and derivatives, (N07BC) Drugs used in opioid dependence, and (A06AH)
Peripheral opioid receptor antagonists. That is, we retrieve active ingredients of opioid drugs. Us-
ing the UMLS CUI mappings we retrieve classes related to these opioid drug ingredients from the
RxNorm terminology. RxNorm terminology has different classes pertaining to drug formulations
(e.g., Morphine Sulfate 50 Mg), drug combinations (e.g., Atropine/Morphine), trade names, etc.
Each RxNorm class may have a distinct CUI code and an RxCUI code. We retrieve these class
relations through a fixed set of properties: Ingredients Of, Has Form, Form Of, Part Of, Ingredient
Of, Consists Of, Constitutes, Has Tradename, and Precise Ingredient Of.
2.2 EMR DATA COLLECTION
The Electronic Medical Record (EMR) data is de-identified and is aggregated in structured form
from more than 400 hospitals and healthcare facilities from across 42 states in US (59% South, 17%
West, 13% Midwest, 12% Northeast) during 2009-2016. The mix of hospitals consist of large and
small facilities in both urban (87%) and rural (13%) locations. Roughly 98% of providers submit
both inpatient and outpatient data. The dataset includes hundreds of variables, such as each patient’s
demographics, diagnoses, procedures and prescribed medications; also, the type and location of
facilities and utilization costs. Data from psychiatric admission facilities were excluded from the
dataset due to HIPAA rules (Annas et al., 2003). The aggregated EMR data is stored in the Google
BigQuery Analytics data warehouse (Tigani & Naidu, 2014).
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Figure 1: Opioid Drug Knowledge Graph: All the classes and their associated relations in the ODKG are
visualized using a force-directed network layout. The different classes — RxNorm drugs, RxNorm generic
ingredients, CUIs, and ATC drug classes, are shown as red diamond, yellow square, blue circle, and green
square nodes respectively. The directed edges indicate a relation (e.g., subClassOf, hasCUI, or any property
listed in Section 2.1) between the linked classes. The Morphine-specific network is shown in greater detail.
2.3 NORMALIZATION OF MEDICATION INFORMATION IN THE EMR DATA WAREHOUSE
Drugs administered to patients in different healthcare sites across the US are recorded and stored
using site-specific identifiers with drug strings (e.g., Duramorph 10mg/10ml EA, Morphine Sulfate
(Concentrate) 10 mg/0.5ml OR Soln, Roxanol Liquid 120ml all include the active ingredient Mor-
phine). We extract a list of 425,059 unique drug strings from the aggregated EMR data warehouse.
MedEx is a natural language processing system to extract medication information from clinical free
text (Xu et al., 2010). We use MedEx to parse these drug strings and extract drug name (e.g.,
Morphine Sulfate), strength (e.g., 10 mg/0.5ml), dosage forms (e.g., OR Soln), etc. Drug names are
mapped with corresponding CUIs and RxCUIs and ODKG classes are instantiated with these drug
strings. It should be noted that one drug string can be mapped to multiple CUIs or RxCUIs.
3 RESULTS
High resolution visualizations and detailed results for this research are made available online at
https://github.com/maulikkamdar/ODKG.
3.1 CHARACTERISTICS OF THE OPIOID DRUG KNOWLEDGE GRAPH
The Opioid Drug Knowledge Graph (ODKG), extracted from the ATC and RxNorm terminologies,
has a hierarchical classification backbone with 97 ATC drug classes, 48 generic RxNorm drug ingre-
dients, 4,960 other RxNorm classes (i.e., combinations, formulations, and ingredients), 5,051 CUI
nodes and 5,188 RxCUI annotations, and 13,581 semantic relations of the type subClassOf, has-
CUI, or any of the above-mentioned property types (see Section 2.1). The ODKG is visualized in
Figure 1, with the Morphine-related community highlighted in more detail. The different classes —
RxNorm drugs, RxNorm generic ingredients, CUIs and ATC drug classes are shown as red diamond,
yellow square, blue circle, and green square nodes respectively. A directed edge between two ATC
drug classes represents the subClassOf relation, whereas a directed edge between an active ingredi-
ent and an RxNorm node indicates a relation between those two classes subscribed under a property
type. Each RxNorm node is associated with CUI node(s). Representation of clinical knowledge in
graphical format enables ease of querying and abstraction of different drug strings. For example, as
shown in Table 1, first degree hops from the generic ingredient Morphine enables the retrieval of
different drug combinations, tradenames, formulations, and dosages.
3.2 EFFICACY OF MEDEX FOR NORMALIZING MEDICATION INFORMATION
There were 425,059 unique drug strings in EMR data warehouse. After extracting medication in-
formation using MedEx, 288,983 drug strings are mapped to at least 1 CUI (68% coverage), and
374,208 drug strings are mapped to at least 1 RxCUI (88% coverage). The opioid-related drug
classes are instantiated with the normalized drug strings. There are 29 opioid-related active ingre-
dients classes in the ODKG which have more than 10 drug strings from the EMR data warehouse
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Figure 2: A) Total number of unique drug strings in the EMR data warehouse instantiated under the generic
opioid classes in the ODKG. B) Florida region-wise visualization of unique prescription occurrences for three
types of opioids: Fentanyl, Morphine, and Oxycodone. C) Increase or decrease in opioid prescriptions across
selected US regions with more than 10,000 unique prescriptions for a particular opioid at a specific time period.
instantiated under them. It can be seen in Figure 2A that certain opioid painkillers, such as Mor-
phine, Oxycodone, Hydromorphone, as well as synthetic opioids, such as Fentanyl, may have more
than 1,000 drug strings instantiated under them. This demonstrates the efficacy of the ODKG toward
drug string normalization in clinical data from across multiple centers.
3.3 SUMMARY STATISTICS ACROSS LOCATION AND TIME
We show a small application of using ODKG in conjunction with the aggregated EMR data ware-
house to generate summary statistics of prescriptions of different opioids. Opioid prescriptions
are categorized according to different US regions as well as different time periods (as determined
through admission year of the patient). Figure 2B shows a visualization of the Florida state where
it can be observed that the Miami region in Florida has ≈ 60,000 unique Fentanyl prescriptions.
Moreover, as seen in Figure 2C, there is a distinct bump in the rate of Fentanyl prescriptions around
2012. Figure 2C also shows selected US regions that demonstrate more than 10,000 unique pre-
scriptions for either Fentanyl, Morphine, or Oxycodone, in a specific year. Such visualizations may
be used for hypothesis generation (e.g., increase in opioid prescription for a particular region).
4 DISCUSSION
Heterogeneous drug names and drug composition pose a significant challenge in performing data
science and machine learning to study the opioid epidemic. In this work, we address this challenge
by developing the Opioid Drug Knowledge Graph (ODKG), the first knowledge graph that captures
how opioid drugs relate to each other. This knowledge graph makes it straightforward to translate
medications from diverse electronic medical records into a common set of chemical-dosage features,
which subsequently enables a large number of prediction and modeling tasks.
In order to identify the best strategies to reduce opioid over-prescription and misuse, a better un-
derstanding of country and regional consumption patterns, pharmaceutical industry influences, and
sociopolitical factors that impact consumption, is needed. Our ODKG will be used to develop a
web-based tool that can facilitate visualization of historical patterns and can enable comparisons
across opioids, time, and US regions. Since our ODKG was data-driven, we hope to further refine it
by consulting with a domain expert and tailor it for specific use cases and end users.
Additionally, we have identified several next steps for further research. We plan to compare our
approach against the OMOP-based approach of transformation of clinical data (Hripcsak et al.,
2015). Potential areas of application include the development of dynamic phenotyping methods to
visually analyze individual pain medication use profiles, to identify potential risk factors for long-
term use, and to detect adverse outcomes for incident user of prescription opioids, specific to the
surgical setting, which some experts now consider the new ‘gateway’ to drug abuse.
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